Clinical Studies on Silybin Phytosome
Clinical Study – Ref11P1
Department of Biochemistry
Faculty of Medicine
National University of Singapore
3rd International Symposium on Flavonoids in Biology & Medicine
November 1989
Liver Protective Activity of IdB 1016 (Silybin Phytosome) A new Flavanolignan Complex
M. Conti, S. Malandrino, M.J. Magistretti*
Inverni della Beffa Research and Development Laboratories, Milan, Italy
No reference on Medline
IThis substance was tested against its constituents (Silybin and Phosphotidylcholine) for protection against liver poisoning in lab rats. IdB 1016 (Silybin Phytosome) was found to reduce liver cell damage indicators from one poison tested by 43%. For another poison it reduced liver necrosis from 68% in poisoned controls to 5% in treated animals.
The compound was consistently more active than either Silybin or Phosphatidylcholine alone. These results may be explained by the improved bioavailablity of IdB 1016 (Silybin Phytosome)
Topics
- Clinical Studies on Silybin Phytosome
- Clinical Study – Ref20C15
- Clinical Study – Ref21C13
- Clinical Study – Ref8P22
- Clinical Study – Ref18C14
- Clinical Study – C10
- Clinical Study – C3Medline
- Clinical Study – Ref9C8
- Clinical Study – Ref12P19
- Clinical Study – Ref13P6
- Clinical Study – Ref14P13
- Clinical Study – Ref15P16
- Clinical Study – Ref16P23
- Clinical Study – Ref19C6
- Clinical Study – C6Medline
- Clinical Study – Ref7P12
- Clinical Study – Ref11P1
